Trade-Offs by Whom for Whom? A Response to Calow
We welcome Calow's (2019) critique of our recent manuscript (Chiapella et al. 2019) and the opportunity to elaborate a few key points. Calow's argument that governance must come to terms with trade-offs between health risks and “benefits from industrial and agrichemicals and pharmaceuticals in terms of lifestyle, food supply, and health,” has already been the key logic underpinning the current regime of toxic chemical governance. This framing has resulted in extreme inequities in exposure to chemical risk and in the distribution of their benefits.
Focusing on the need for improved CBA, while welcome, does not address our more substantive claim: that toxic chemical governance failure has resulted from...
Locate the Document
Grabowski, Z. J., Chiapella, A. M., Alattar, M. A., Denton, A. D., Rozance, M. A., & Granek, E. F. (2019). Trade-Offs by Whom for Whom? A Response to Calow. BioScience, 69(12), 954-955.